NDA 204395 describes SODIUM PHENYLBUTYRATE, which is a drug marketed by
Endo Operations,
Sigmapharm Labs Llc,
Alvogen, and
Glenmark Pharms Ltd, and is included in five NDAs. It is available from
three suppliers. Additional details are available on the
SODIUM PHENYLBUTYRATE profile page.
The generic ingredient in SODIUM PHENYLBUTYRATE is
sodium phenylbutyrate. There are one thousand four hundred and seventy-two
drug master file entries for this compound. Six
suppliers are listed for this compound. Additional details are available on the
sodium phenylbutyrate profile page.